Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Long-term survival of the uncemented Balgrist total hip replacement cup

J. Gallo, J. Lostak, K. Langova,

. 2013 ; 37 (8) : 1449-1456.

Jazyk angličtina Země Německo

Typ dokumentu hodnotící studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14064152

Grantová podpora
NT11049 MZ0 CEP - Centrální evidence projektů
NT14267 MZ0 CEP - Centrální evidence projektů

PURPOSE: The purpose of this study was to evaluate the long-term clinical and radiographic outcomes of the Balgrist total hip replacement cup. METHODS: We report the results of a retrospective review of 195 total hip prostheses with Balgrist cup implanted in 178 patients. There were 59 men and 119 women with a mean age at surgery of 52.3 years (range, 19-72). Cox regression was used to determine the influence of independent variables on the survivorship of the prosthesis. RESULTS: There were 117 (66 %) of 178 patients, and 131 (67 %) of 195 hips available for assessment at a mean follow-up of 17.4 years. A total of 21 patients (22 hips) were lost from follow-up (12 %). A total of 25 patients (27 hips) required some type of re-operation during the follow-up period. Eight of 27 re-operations (30 %) were directly caused by the Balgrist cup failure due to fatigue fracture of the metallic shell (n = 5; 19 %), polyethylene wear (n = 2; 7 %) and aseptic loosening (n = 1; 4 %). The mean polyethylene wear rate was 0.068 mm/year (range, 0.008-0.230; SD = 0.043). The risk of re-operation for any reason was decreased with dysplastic hip as a primary diagnosis (hazard ratio; HR = 0.250; 95 % CI 0.086-0.725) and with greater age at the time of surgery (HR = 0.923; 95 % CI 0.880-0.969). The 19-year survivorship with re-operation for any reason was 75.6 % (95 % CI 67.0-84.2). The 19-year survivorship with re-operation for the Balgrist cup failure was 90.5 % (95 % CI 83.4-97.6). CONCLUSIONS: The Balgrist cup continues to provide excellent clinical and radiological outcomes. This is associated at least in part with a low polyethylene wear rate. The main reason for the Balgrist cup failure is fatigue fracture of the metallic shell.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14064152
003      
CZ-PrNML
005      
20190708085929.0
007      
ta
008      
140704s2013 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00264-013-1946-x $2 doi
035    __
$a (PubMed)23744502
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Gallo, Jiří $u Department of Orthopaedics, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital, I. P. Pavlova 6, 77520, Olomouc, Czech Republic. jiri.gallo@volny.cz $7 xx0019005
245    10
$a Long-term survival of the uncemented Balgrist total hip replacement cup / $c J. Gallo, J. Lostak, K. Langova,
520    9_
$a PURPOSE: The purpose of this study was to evaluate the long-term clinical and radiographic outcomes of the Balgrist total hip replacement cup. METHODS: We report the results of a retrospective review of 195 total hip prostheses with Balgrist cup implanted in 178 patients. There were 59 men and 119 women with a mean age at surgery of 52.3 years (range, 19-72). Cox regression was used to determine the influence of independent variables on the survivorship of the prosthesis. RESULTS: There were 117 (66 %) of 178 patients, and 131 (67 %) of 195 hips available for assessment at a mean follow-up of 17.4 years. A total of 21 patients (22 hips) were lost from follow-up (12 %). A total of 25 patients (27 hips) required some type of re-operation during the follow-up period. Eight of 27 re-operations (30 %) were directly caused by the Balgrist cup failure due to fatigue fracture of the metallic shell (n = 5; 19 %), polyethylene wear (n = 2; 7 %) and aseptic loosening (n = 1; 4 %). The mean polyethylene wear rate was 0.068 mm/year (range, 0.008-0.230; SD = 0.043). The risk of re-operation for any reason was decreased with dysplastic hip as a primary diagnosis (hazard ratio; HR = 0.250; 95 % CI 0.086-0.725) and with greater age at the time of surgery (HR = 0.923; 95 % CI 0.880-0.969). The 19-year survivorship with re-operation for any reason was 75.6 % (95 % CI 67.0-84.2). The 19-year survivorship with re-operation for the Balgrist cup failure was 90.5 % (95 % CI 83.4-97.6). CONCLUSIONS: The Balgrist cup continues to provide excellent clinical and radiological outcomes. This is associated at least in part with a low polyethylene wear rate. The main reason for the Balgrist cup failure is fatigue fracture of the metallic shell.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a náhrada kyčelního kloubu $x přístrojové vybavení $7 D019644
650    _2
$a kostní cementy $7 D001843
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a luxace kyčle $x chirurgie $7 D006617
650    _2
$a kyčelní kloub $x radiografie $x chirurgie $7 D006621
650    12
$a kyčelní protézy $7 D006622
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a Kaplanův-Meierův odhad $7 D053208
650    _2
$a longitudinální studie $7 D008137
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a artróza kyčelních kloubů $x chirurgie $7 D015207
650    _2
$a polyethylen $7 D020959
650    _2
$a proporcionální rizikové modely $7 D016016
650    12
$a protézy - design $7 D011474
650    _2
$a reoperace $x přístrojové vybavení $x statistika a číselné údaje $7 D012086
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a výsledek terapie $7 D016896
655    _2
$a hodnotící studie $7 D023362
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lošťák, Jiří $7 xx0199227
700    1_
$a Langová, Kateřina $7 xx0141371
773    0_
$w MED00002384 $t International orthopaedics $x 1432-5195 $g Roč. 37, č. 8 (2013), s. 1449-1456
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23744502 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20190708090126 $b ABA008
999    __
$a ok $b bmc $g 1031636 $s 862884
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 37 $c 8 $d 1449-1456 $i 1432-5195 $m International orthopaedics $n Int Orthop $x MED00002384
GRA    __
$a NT11049 $p MZ0
GRA    __
$a NT14267 $p MZ0
LZP    __
$a Pubmed-20140704

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...